Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

In this episode, I talked with Dr. Dena Grayson, a physician–scientist with over two decades in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at Keros Therapeutics, leading programs in rare bone marrow disorders, and she has since become SVP of Clinical Development and Medical Affairs at Kyverna Therapeutics. Earlier in her career, she helped advance Repatha at Amgen, and her path has also included running for Congress and serving as a national media voice during COVID.

Dena shares what it was like being the only MD–PhD in Amgen’s business development group, how she transitioned into clinical development, and the lessons she carried forward from her time in both politics and national media, where she became a trusted voice during the COVID pandemic. We dive into the real difference between presenting “the what” and explaining “the so what,” and why communication often makes or breaks careers in biotech.

Alongside her professional journey, Dena opens up about the wildest recruitment experience she’s ever had, her approach to building strong teams, and why patience in hiring beats rushing a decision. And in our quick-fire round, she shares stories from her days as a state champion soccer player, her love of surfing, and how she unwinds outside biotech.

(Find out more in the episode.)

Here’s What You’re In For

  1. How a political campaign loss led to a media career during COVID
  2. How to handle interviews when you’re introverted
  3. The kinds of questions that truly impress hiring managers


Timestamps

01:10 – Landing her first industry role at Amgen

03:24 – Repatha and investigational therapies at Keros

04:49 – Surfing, soccer, and state championships

07:08 – From political spouse to running for Congress

08:42 – Becoming a media commentator during COVID

10:41 – Communication lessons: from “what” to “so what”

15:14 – Advice for introverts in interviews and early career roles

17:37 – How thoughtful questions can change the dynamic in an interview

21:02 – Nearly 20 years as a hiring manager: what’s changed and what hasn’t

23:11 – Advice for junior hiring managers and why patience matters

25:37 – A candidate with a completely fabricated CV—the wildest recruitment story


About Dena

Dr. Dena Grayson is a physician–scientist (MD, PhD) with over 20 years in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at Keros Therapeutics, leading programs in rare bone marrow disorders, and she has since become SVP of Clinical Development and Medical Affairs at Kyverna Therapeutics. Earlier in her career, she helped advance Repatha at Amgen, and her path has also included running for Congress and serving as a national media voice during COVID, experiences that shaped her belief that communication is as critical as science in driving biotech forward.

Connect with Dena:

  1. LinkedIn: https://www.linkedin.com/in/denaminninggrayson/
  2. Website: https://kyvernatx.com/


About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

  1. LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
  2. Website: https://www.discera-search.com/



Opinions and comments expressed by the guest do not represent the company and are fully their own.

Jaksot(67)

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Maalis 42min

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

In this episode, I talked with Volker Wacheck, SVP & Head of Clinical Development at Taiho Oncology, where he shared how a PI role in Vienna led him into industry, and why the hardest part wasn’t leav...

9 Maalis 29min

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

In this episode, I talked with Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, a Copenhagen-based biotech developing GIPR antagonists in the obesity space.Richard’s career began in ...

26 Tammi 35min

Prof. Dr. med. Markus Kosch, Head of Oncology Europe & Canada at Daiichi Sankyo on Perseverance, Patient-Centricity Beyond Slogans, and Leadership within Oncology

Prof. Dr. med. Markus Kosch, Head of Oncology Europe & Canada at Daiichi Sankyo on Perseverance, Patient-Centricity Beyond Slogans, and Leadership within Oncology

In this episode, I talked with Prof. Dr. med. Markus Kosch, Head of Oncology Europe and Canada at Daiichi Sankyo Europe, about what it really means to lead with empathy, perseverance, and purpose in t...

19 Tammi 35min

Myriam Cherif, Founder of Kalyx Medical, on The Future of MSLs, Adapting to AI, and Why Curiosity Keeps You Moving Forward

Myriam Cherif, Founder of Kalyx Medical, on The Future of MSLs, Adapting to AI, and Why Curiosity Keeps You Moving Forward

In this episode, I talked with Myriam Cherif, former Regional Medical Lead for Oncology & Emerging Markets at GSK and founder of Kalyx Medical—a consultancy focused on Medical Affairs strategy, mentor...

5 Tammi 33min

Sven Van den Berghe, CEO of Pantera on Overpromises in Isotope Marketing, Why Culture is the Company, and Discussions in RLT Development

Sven Van den Berghe, CEO of Pantera on Overpromises in Isotope Marketing, Why Culture is the Company, and Discussions in RLT Development

In this episode, I talked with Sven Van den Berghe, CEO of Pantera, about his 25+ years in nuclear physics, from his early days at the Belgian Nuclear Research Center to stepping into the high-stakes ...

17 Marras 202527min

Catello Somma, Partner at Seroba on Working in VC, Non-Linear Biotech Careers, and advice for those seeking VC careers

Catello Somma, Partner at Seroba on Working in VC, Non-Linear Biotech Careers, and advice for those seeking VC careers

In this episode, I talked with Catello Somma, Partner at Seroba, to learn about his nonlinear journey from academia and biopharma into venture capital—and the realities behind building funds, backing ...

10 Marras 202521min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
hyva-paha-johtaminen
rss-oivalluksia-rahasta-elamasta
rss-rahamania
inderespodi
rss-lahtijat
ostan-asuntoja-podcast
rahapuhetta
oppimisen-psykologia
lakicast
rss-bisnesta-bebeja
rss-sisalto-kuntoon
rss-inderes
leadcast
mihin-sita-saastais
rss-rikasta-elamaa
rss-40-ajatusta-aanesta